Skip to main content

Achievements in the year 2018-19

Ayushman Bharat-PM Jan Arogya Yojana

NITI Aayog has played a significant role in strengthening the Ayushman Bharat Scheme. It held extensive peer review of health benefits packages for PMJAY and recommended 1352 packages. Its recommendations included adding packages on emergency room packages and mental care packages, etc.  NITI also suggested measures for incentivizing healthcare quality and service uptake in Aspirational districts through the development of Standard Treatment Workflow and Costing for Health Benefit Packages.

 

NITI Aayog consulted various stakeholders and developed way forward titled ‘Building Safeguards and System Fencing Against Opportunistic Malpractice” in Ayushman Bharat.

 

Image removed.Health Outcome Index - Assessing the Performance of States on Health Outcomes

NITI Aayog in collaboration with the Ministry of Health & Family Welfare (MoHFW) and with technical assistance of the World Bank has been spearheading the Health Index initiative from 2017 to measure the annual performance of States and UTs on a variety of indicators – Health Outcomes, Governance, and Processes.

 

Aspirational District Programme

NITI Aayog is partnering with Piramal Foundation on pro bono basis in 25 Aspirational Districts which are exclusively assigned to NITI Aayog. In these districts, NITI-Pirmal Team is fostering the transformation in the health and nutrition sectors with the involvement of district officers under the leadership of District Collectors. The district action plans are prepared for effecting the transformation in the health and nutrition sectors facilitated by development specialists at district and block levels.

 

Reforms in the Medical Council of India

The draft National Medical Commission Bill with amendments based on the recommendations of the Parliamentary Standing Committee was made in collaboration with MOHFW and which was approved by the Union Cabinet.

 

Reforms in the Homeopathy Central Council Act and the Indian Medicine Central Council Act

NITI Aayog examined and made recommendations to the draft National Commission for Homoeopathy (NCH) Bill, 2018, National Commission for Indian System of Medicine Bill, 2018 and National Commission for Yoga & Naturopathy Bill, 2018 

 

Evaluation of Population Research Centres (PRCs)

The vertical held consultative meetings with representatives from PRCs, IIPS Mumbai, PHR and Deptt. of H&FW   in the month of June 2018 to address the various issues pertaining to PRCs.

 

Review of social marketing schemes

The Committee under the chairmanship of the Vice Chairman, NITI Aayog,   examined the scheme on social marketing of contraceptives and recommended for its continuation till the year 2020. 

 

Providing Functional autonomy to IMS BHU

Officials of the Vertical at NITI Aayog, held extensive deliberations on providing functional autonomy to IMS BHU, with MoHFW, MoHRD/UGC and Institute of Medical Science (IMS), Banaras Hindu University (BHU). It was decided to transform the governance, functioning and performance of the IMS, BHU. An MoU  on this was  signed between AIIMS, New Delhi MoHRD, MoHFW and BHU.

 

Image removed.Provision of prevention and treatment services for Non-Communicable diseases

The Vertical developed model concession agreements on PPP mode, for the provision of prevention and treatment services for Non-Communicable diseases (cardiac sciences, oncology, and pulmonary sciences)  at the district level. The document was released in October, 2018

 

Tracking the performance of District hospitals

A framework was designed to carry out a holistic assessment of hospitals, which included selected indicators based on which the performance of district hospitals could be measured.   The process to hire a third party for validation of data in the field has been initiated.

 

Reforms in the Pharmaceutical and Medical Device sector:

  1. Pharmaceutical pricing reforms:   A detailed report carrying inputs for reforms in the sector was submitted to the Department of Pharmaceuticals (DoP) highlighting the concerns and suggested roadmap. The proposed amendments in DPCO are under consideration with the government.

  2. Trade Margin Rationalisation: NITI had put up a consultation paper on its official website inviting public comments on ‘Rationalisation of Trade Margins for Medical Devices’; the matter is under consideration.

  3. Ease of Doing Business:

    1. Universal and Expeditious adoption of GMPs: NITI Aayog   lead a policy development   with the DIPP, DoP, MSME and DoHFW and ‘to come up with a suitable scheme to incentivize the industries for switching over to GMPs’. The key decisions arrived on, mandatory adoption of schedule M-GMP compliance at par with WHO-GMP 2017 standards; ensuring GMP compliance by the entire industry by end of 2019.

    2.  Effective Implementation of Sugam Portal:

      1. NITI Aayog after due consultations with DoP and Drug Controller General of India (DCGI), decided to incorporate submission of data with respect to licensed manufacturing units and drugs by self-declaration by the manufacturers on the SUGAM portal.

      2. Accordingly, an amendment in the Drugs & Cosmetics Rule was considered by MoHFW and a draft notification was also issued on 11th July 2018 for soliciting public comments.

    3. Streamlining the process of approval of new drug regulation. The  key actions initiated are:

      1. Streamlined Stem cell and cell based research approval by authorising the national level Cell Biology Based Therapeutic Drugs Evaluation Committee (CBBTDEC) as the single committee to grant approval instead of the earlier three-step approval process.

      2. Facilitation cell (FIRST HUB) for biomedical device innovators set up by BIRAC as a single platform for interface with government stakeholders and resolution of their queries.

      3. Guidelines for therapeutic use (Commercial use) of stem cells and cell-based products are being developed; will be accomplished in a phased manner over the next three months by an expert group led by ICMR.

      4. Genetherapy and Immunotherapy research guidelines being developed by ICMR and proposed to be released in next 3 months.

      5. Clinical trial application submission and tracking has been made online through SUGAM.

      6. MoH&FW recently notified the Draft New Drug and Clinical Trial Rules 2018. These rules, interalia, have a provision for giving market authorisation by the regulator within 30 days, with a provision for deemed approval.

      7. A public relation office (PRO) has been set up at the office of DCGI (CDSCO) as a s ingle window grievance resolution window for obtaining clarification on any regulatory issues pertaining to drugs and pharmaceuticals.

    4. Incentivizing manufacturing of Medical Devices in India

      1. NITI Aayog steered a process   to develop policy interventions for incentivizing manufacturing of medical devices in India. The process identified areas of action on separate legislation for Medical Device, strengthening of institutional structure of CDSCO,   constitution of a Medical Device Technical Advisory Group, setting up of 2-3 medtech zones in addition to AMTZ; strengthening the labs and testing  etc.

 

Standards and Certifications of medical devices

To give a fillip to ‘Make in India’ in medical devices and ensure that medical devices manufactured, sold, procured and imported in the country, confirm to internationally benchmarked standards, the Vertical has taken up the matter separately. This is vital for patient safety, to increase investments in the sector and to boost exports of indigenously manufactured devices.

 

Building Capacities for increase in medical specialist seats in India:

NITI has engaged with the National Board of Examinations, private sector hospitals through Industry bodies and organized sector like Armed force medical services (AFMS), Railway Health Service (RHS) and Employee State Insurance corporation (ESIC) for identifying way forward to increase the intake and training of specialist programmes in the country.

 

Development of Public Health Cadre:

NITI has initiated a work stream to develop a framework for development of Public Health Cadre at Central and State level. The work has been initiated, consultations with various stake holders have already been completed.

 

NHM Evaluation:

NITI has initiated process for identifying suitable arrangements to conduct the study in a time bound manner to evaluate the NHM since its last evaluation in 2011. 

 

Reforms in Nursing Education

NITI Aayog conducted a brainstorming session for transforming Nursing education in India in a view to provide quality health care to New India. In this regard, the Division is proposing  to come out with a model cadre for nurses with assured career progress.

 

Developing framework for improving skills of allied health care professionals

The Vertical is working on developing a framework for improving the level and quality of education imparted to these professionals and improving the skills of the workforce.

​​​​​​​